Scannell JW, Bosley J (2016) When quality beats quantity: decision theory, drug discovery, and the reproducibility crisis. PLoS ONE. https://doi.org/10.1371/journal.pone.0147215
Article PubMed PubMed Central Google Scholar
Santos R, Ursu O, Gaulton A et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19–34. https://doi.org/10.1038/nrd.2016.230
Article CAS PubMed Google Scholar
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
Article CAS PubMed Google Scholar
Dandapani S, Marcaurelle LA (2010) Grand challenge commentary: accessing new chemical space for “undruggable” targets. Nat Chem Biol 6:861–863. https://doi.org/10.1038/nchembio.479
Article CAS PubMed Google Scholar
Kodadek T (2011) The rise, fall and reinvention of combinatorial chemistry. Chem Commun 47:9757–9763. https://doi.org/10.1039/c1cc12102b
Borman S (2002) Combinatorial chemistry. Chem Eng News 80:43–57. https://doi.org/10.1021/cen-v080n045.p043
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335. https://doi.org/10.1021/np200906s
Article CAS PubMed PubMed Central Google Scholar
Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43:218–227. https://doi.org/10.1021/ci0200467
Article CAS PubMed Google Scholar
Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:3670–3695. https://doi.org/10.1016/J.BBAGEN.2013.02.008
Article CAS PubMed Google Scholar
Hong J (2011) Role of natural product diversity in chemical biology. Curr Opin Chem Biol 15:350–354. https://doi.org/10.1016/J.CBPA.2011.03.004
Article CAS PubMed PubMed Central Google Scholar
Rosén J, Gottfries J, Muresan S, Backlund A, Oprea TI (2009) Novel chemical space exploration via natural products. J Med Chem 52:1953–1962. https://doi.org/10.1021/jm801514w
Article CAS PubMed PubMed Central Google Scholar
Henkel T, Brunne RM, Müller H, Reichel F (1999) Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 38:643–647. https://doi.org/10.1002/(SICI)1521-3773(19990301)38:5%3C643::AID-ANIE643%3E3.0.CO;2-G
Barelier S, Eidam O, Fish I, Hollander J, Figaroa F, Nachane R, Irwin JJ, Shoichet BK, Siegal G (2014) Increasing chemical space coverage by combining empirical and computational fragment screens. ACS Chem Biol 9:1528–1535. https://doi.org/10.1021/cb5001636
Article CAS PubMed PubMed Central Google Scholar
Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432:829–837. https://doi.org/10.1038/nature03194
Article CAS PubMed Google Scholar
Galloway WRJD, Isidro-Llobet A, Spring DR (2010) Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun 1:1–13. https://doi.org/10.1038/ncomms1081
Spring DR (2003) Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem 1:3867–3870. https://doi.org/10.1039/b310752n
Article CAS PubMed Google Scholar
Burke MD, Schreiber SL (2004) A planning strategy for diversity-oriented synthesis. Angew Chem Int Ed 43:46–58. https://doi.org/10.1002/anie.200300626
Burke MD, Lalic G (2002) Teaching target-oriented and diversity-oriented organic synthesis at Harvard University. Chem Biol 9:535–541. https://doi.org/10.1016/S1074-5521(02)00143-6
Article CAS PubMed Google Scholar
Galloway WRJD, Bender A, Welch M, Spring DR (2009) The discovery of antibacterial agents using diversity-oriented synthesis. Chem Commun. https://doi.org/10.1039/B816852K
Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein–protein interactions: progressing towards the dream. Nat Rev Drug Discov 3:301–317. https://doi.org/10.1038/nrd1343
Article CAS PubMed Google Scholar
Surade S, Blundell TL (2012) Structural biology and drug discovery of difficult targets: the limits of ligandability. Chem Biol 19:42–50. https://doi.org/10.1016/J.CHEMBIOL.2011.12.013
Article CAS PubMed Google Scholar
Jiang J, Hui C (2008) Hedgehog signaling in development and cancer. Dev Cell 15:801–812. https://doi.org/10.1016/J.DEVCEL.2008.11.010
Article CAS PubMed PubMed Central Google Scholar
Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW (2016) Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers (Basel) 8:1–23. https://doi.org/10.3390/cancers8020022
O’Connor CJ, Beckmann HSG, Spring DR (2012) Diversity-oriented synthesis: producing chemical tools for dissecting biology. Chem Soc Rev 41:4444–4456. https://doi.org/10.1039/C2CS35023H
Peng LF, Stanton BZ, Maloof N, Wang X, Schreiber SL (2009) Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog. Bioorg Med Chem Lett 19:6319–6325. https://doi.org/10.1016/J.BMCL.2009.09.089
Article CAS PubMed PubMed Central Google Scholar
Stanton BZ, Peng LF, Maloof N et al (2009) A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol 5:154–156. https://doi.org/10.1038/nchembio.142
Article CAS PubMed PubMed Central Google Scholar
Thomas GL, Spandl RJ, Glansdorp FG et al (2008) Anti-MRSA agent discovery using diversity-oriented synthesis. Angew Chem Int Ed 47:2808–2812. https://doi.org/10.1002/anie.200705415
Fernandes P (2006) Antibacterial discovery and development—the failure of success? Nat Biotechnol 24:1497–1503. https://doi.org/10.1038/nbt1206-1497
Article CAS PubMed Google Scholar
Ash C (1996) Antibiotic resistance: the new apocalypse? Trends Microbiol 4:371–372. https://doi.org/10.1016/0966-842X(96)30028-0
Article CAS PubMed Google Scholar
Sun Y, Zhang J, Zhang Y, Liu J, van der Veen S, Duttwyler S (2018) The closo-dodecaborate dianion fused with oxazoles provides 3D diboraheterocycles with selective antimicrobial activity. Chem Eur J 24:10364–10371. https://doi.org/10.1002/chem.201801602
Article CAS PubMed Google Scholar
Tietze LF, Bell HP, Chandrasekhar S (2003) Natural product hybrids as new leads for drug discovery. Angew Chem Int Ed 42:3996–4028. https://doi.org/10.1002/anie.200200553
Mehta G, Singh V (2002) Hybrid systems through natural product leads: an approach towards new molecular entities. Chem Soc Rev 31:324–334. https://doi.org/10.1039/b204748a
Article CAS PubMed Google Scholar
Soosay Raj TA, Smith AM, Moore AS (2013) Vincristine sulfate liposomal injection for acute lymphoblastic leukemia. Int J Nanomed 8:4361–4369. https://doi.org/10.2147/IJN.S54657
Song KM, Park SW, Hong WH, Lee H, Kwak SS, Liu JR (1992) Isolation of vindoline from Catharanthus roseus by supercritical fluid extraction. Biotechnol Prog 8:583–586. https://doi.org/10.1021/bp00018a018
Article CAS PubMed Google Scholar
Arias HR, Feuerbach D, Targowska-Duda KM, Jozwiak K (2010) Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors. Neurochem Int 57:153–161. https://doi.org/10.1016/J.NEUINT.2010.05.007
留言 (0)